8-K filing — NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Filed: 2026-09-10 AccNo: 0001829126-26-009977 Size: 891 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stocks · News reference
NeOnc Technologies Enters $15M Securities Purchase Agreements In At‑The‑Market Offering
NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical company developing novel therapies for central nervous system (CNS) cancers,
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
NeOnc Technologies Holdings shares are trading lower. The company announced a $15 million registered direct offering.
BTIG Reiterates Buy on NeOnc Technologies Hldgs, Maintains $15 Price Target
BTIG analyst Thomas Shrader reiterates NeOnc Technologies Hldgs (NASDAQ:NTHI) with a Buy and maintains $15 price target.